The answer: Nicotine pouches are nicotine delivery products placed under the lip, and yes, they are addictive, because addiction is produced by nicotine itself, not by the tobacco that traditionally delivered it.
What they are
Small white pouches with nicotine, water, plant-based filler, and flavoring placed between the upper lip and gum. Nicotine is absorbed through the oral mucosa over 30 to 60 minutes. No tobacco leaf. No combustion. No smoke. Heavily flavored (mint, fruit, coffee), making them palatable to users who would not tolerate unflavored tobacco.
Available in 2 mg to 8 mg strengths. In India, available online in a regulatory vacuum and in urban retail- marketed primarily to young urban consumers as a modern, discreet, tobacco-free nicotine experience.
Are they addictive?
Yes, unambiguously. Nicotine dependence is produced by nicotine, not by tobacco specifically. The receptor upregulation, dopamine disruption, and withdrawal state that smoking produces are all produced by nicotine regardless of delivery vehicle. Studies confirm dependence development in pouch users- withdrawal on cessation, difficulty stopping, escalating use as tolerance builds.
The harm reduction argument and its limits
For existing smokers unable to quit nicotine entirely, pouches remove combustion-related harm- lung cancer, COPD, cardiovascular disease from carbon monoxide and tar. This argument has merit in that specific context. But smokers can resort to NRT in this case and not depend on nicotine pouches, as pouches’ ultimate objective is to keep users dependent.
The limit: pouches are marketed primarily to young non-smokers through flavoring, sleek packaging, and social media- recruiting new nicotine users rather than redirecting existing ones. Harm reduction for smokers and harm creation for non-smokers are happening simultaneously through the same product.
The regulatory gap in India
Nicotine pouches are neither tobacco products under COTPA nor pharmaceutical NRT under drug regulation- existing without standardized dosing verification, consistent age restrictions, or mandatory health warnings. This gap is being actively exploited by manufacturers for whom India is an accessible, under-regulated market. One cigarette contains 10 to 12 mg of nicotine, and smokers get 1 to 2 mg, as the rest burns off in combustion. Nicotine pouches come in variations of 2 mg to even 150 mg due to regulatory gaps. High doses of nicotine can cause death too.
The one thing to hold onto
Some regulated nicotine pouches are less harmful than cigarettes for existing smokers seeking harm reduction. Most are dangerous due to regulatory gaps.
For non-smokers, they are an unnecessary introduction to nicotine dependence dressed in the language of modernity.
The nicotine is the same. The dependence is the same. The packaging is new.
Cignix is India’s neural circuit-based smoking cessation platform. The Cignix Protocol works with the biology of how smoking is learned and how it is unlearned. The entry point is the Smoking Immunity Meter at learn.cignix.com/user/sim. Visit cignix.com.